Especially given not all of the world has a tradition of caring about foreign IP enforcement. Say, post-pandemic and when you'd like to use Moderna's methods for other drugs.

Which, say what you want about IP law, but pharma objectively has the best claim to it -- if we want new drugs and safety, exclusivity periods and sole ownership of IP are the only way to balance the massive initial financial outlay. (Without funding it directly from government)